Managing Cigarette Addiction and Withdrawal
Combine pharmacotherapy with behavioral counseling—this is the most effective approach, with varenicline or combination nicotine replacement therapy (NRT) as first-line pharmacotherapy options. 1, 2
Initial Assessment and Screening
- Screen for tobacco use at every healthcare visit and document it as a vital sign 1
- Ask specifically: "Have you used any tobacco product in the past 30 days?" rather than just "Do you smoke?" 1
- Assess willingness to make a quit attempt now 1
- Firmly advise the patient to quit at every visit using clear, strong, yet compassionate and nonjudgmental language 1
First-Line Pharmacotherapy Options
Varenicline is the most effective single-agent pharmacotherapy, with abstinence rates of 28-33% compared to 12% with placebo. 3, 2, 4
Varenicline Dosing
- Start one week before quit date 5
- Days 1-3: 0.5 mg once daily 5
- Days 4-7: 0.5 mg twice daily 5
- Day 8 onward: 1 mg twice daily for minimum 12 weeks 5
- Extend treatment for an additional 12 weeks (total 24 weeks) for successful quitters to increase long-term abstinence 5
- Most common adverse effect is nausea 3, 2
Combination NRT (Preferred Alternative)
Combining a long-acting nicotine patch with a short-acting NRT product (gum, lozenge, inhaler, or nasal spray) is more effective than single-agent NRT, with abstinence rates of 36.5%. 2, 6
- Nicotine patch provides steady baseline nicotine levels 6, 7
- Short-acting NRT (gum, lozenge, inhaler, nasal spray) addresses breakthrough cravings 3, 2
- Higher doses provide better withdrawal control: use 4 mg gum for heavy smokers (>15 cigarettes/day) rather than 2 mg 2
- Use 25 mg patches over 15 mg patches when appropriate 2
- Extend treatment beyond 14 weeks—prolonged patch therapy is superior to standard duration 3
Bupropion SR
- Can be combined with NRT for patients who fail monotherapy 3
- Bupropion plus nicotine patch is superior to bupropion alone 3
- Contraindicated in patients with brain metastases due to seizure risk 1, 2
Behavioral Counseling Requirements
All pharmacotherapy must be paired with behavioral counseling—even brief 3-minute advice increases quit rates. 3, 2
- Provide at least 4 counseling sessions; optimal outcomes occur with 8+ sessions 3
- Counseling shows a positive dose-response relationship with abstinence 3
- Total contact time of 91-300 minutes is most effective 3
- Combining behavioral support with pharmacotherapy increases cessation rates from 18% to 21% 3
Effective Counseling Components
- Practical problem-solving skills training: recognize high-risk situations, develop coping strategies, create a quit plan 3
- Social support provision 3
- Motivational interviewing 3
- Telephone counseling (minimum 3 calls) is effective and accessible 3
- Refer to free telephone quitlines for ongoing support 1
Managing Nicotine Withdrawal Symptoms
Timeline of Withdrawal
- Symptoms begin within 24 hours of last cigarette 2
- Peak intensity occurs within 1-2 weeks 2
- Acute phase lasts 3-4 days, with symptoms typically extending 3-4 weeks 2
- Cravings peak in the first week but can persist for months 2
- Weight gain occurs in >75% of quitters, averaging 2.8-3.8 kg 2
Pharmacotherapy for Withdrawal Management
- Combination NRT or varenicline are first-line treatments for managing withdrawal symptoms 2
- Higher NRT doses provide superior withdrawal symptom control 2
- NRT blood nicotine levels are significantly lower than from smoking, making it remarkably safe 2
Follow-Up Schedule
- Assess smoking status and medication tolerability within 2-3 weeks of initiating therapy 1, 2
- Continue follow-up at 12 weeks to assess completion of initial therapy course 1, 2
- Provide ongoing support as needed 3
Managing Treatment Failure or Relapse
If initial treatment fails, try a first-line medication not previously used, use combination therapy, or extend treatment duration. 3
- Switch to varenicline if NRT was used initially, or vice versa 3, 2
- Add combination NRT if single-agent NRT failed 3
- Combine bupropion SR with nicotine patch if either alone was ineffective 3
- Consider indefinite NRT treatment to prevent relapse in some patients 3
- Resume or continue initial pharmacotherapy with additional behavioral therapy 2
Important Safety Considerations
- Varenicline: monitor for nausea, neuropsychiatric issues (depression, suicidal ideation); contraindicated with brain metastases 1, 2
- Bupropion: contraindicated with brain metastases; common side effects include dry mouth and insomnia 2
- NRT is remarkably safe with minimal serious adverse events 2, 6
- Chest pains or palpitations are rare but can occur with NRT (OR 1.88) 6
- NRT does not negatively affect wound healing at normal doses 1
Cost-Effectiveness
Tobacco cessation treatments are cost-effective and reduce overall healthcare costs. 3, 8